Click it and Unblock the Notifications
There are 5 pharma equity mutual funds that have given returns above 26% in three years and the average category returns are 24.93% during the same period. Pharma equity mutual funds are sectoral mutual funds. The details are as follows.
| Scheme Name | 6-months returns (%) | YTD Returns (%) | 1-year returns (%) | 3-year returns (%) |
|---|---|---|---|---|
| DSP Healthcare Fund | 3.04 | -4.24 | -1.99 | 28.52 |
| ICICI Prudential Pharma Healthcare And Diagnostics Fund | -1.02 | -3.66 | -5.00 | 27.38 |
| Mirae Asset Healthcare Fund | -5.95 | -5.85 | -9.44 | 26.80 |
| SBI Healthcare Opportunities Fund | 0.79 | -3.57 | -1.99 | 26.58 |
| Nippon India Pharma Fund | -1.63 | -4.63 | -5.93 | 26.11 |
| S&P BSE Healthcare TRI (benchmark) | -4.39 | -5.51 | -10.05 | 23.88 |
| Category Average | -1.93 | -4.93 | -6.47 | 24.93 |
In last one year, pharma mutual funds have underperformed and given negative returns, entire category and benchmark also underperformed. However in three years they managed to turn around and give double digit returns.
Pharma mutual funds are sectoral mutual funds are equity funds that invest in stocks of pharma and healthcare sector unbiased of any market cap. Although pharma is a part of defensive sector, but these funds are more prone to risk as they are concentrated with stocks from one sector. So, if any changes occur due to the regulations from the government, that would adversely impact the overall performance of the schemes.
All the funds considered are growth direct plans, the returns are taken from ValueResearch.
Disclaimer
Mutual fund investments are subject to market risk. The above-mentioned information is purely informational and doesn't guarantee any return. Greynium Information Technologies and the Author are not liable for any losses caused as a result of a decision based on the article.
Sign in with Google